… growth factor receptor-targeting drugs in the treatment of nonsmall cell lung cancer. … factor
receptor inhibitors of tyrosine kinase enzymatic activity that prevent epidermal growth factor …

… as lung cancer therapy. The current review focuses on the role of EGFR in lung cancer …
Particularly, these EGFR inhibitors were successful in suppressing lung cancer progression …

… therapies for lung cancers. This review will discuss the RTKs that are involved in lung cancers
and … We will specifically discuss receptors such as epidermal growth factor receptor, c-Kit …

… treatment of lung cancer is beginning to open, and through these efforts, it will be possible
to slow the progression of lung cancer and eventually, to decrease mortality from lung cancer. (…

… cancer cells. Lung cancer cells had the highest levels of vascular endothelial growth
factors (VEGF) A, B, and C, and of VEGF receptors as compared with colorectal cancer cells. …

… Of the nearly 200,000 people diagnosed with lung cancer each year in the United States, …
cell lung cancer (NSCLC) with somatic mutations in the epidermal growth factor receptor gene (…

… in patients with EGFRm lung cancer who develop disease … tumors respond to the selective
inhibition of third-generation EGFR … In summary, EGFR inhibition in patients with NSCLC has …

… lung cancer cell lines, suggesting that Notch3 activation is a common event in lung cancer
(… in resected, human lung tumors, we probed lung cancer tissue microarrays with an antibody …

… circumvent inhibition … lung cancer cells carry out for growth, proliferation, angiogenesis,
and metastasis by using GFRs, and how they are being cotargeted by small-molecule inhibitors …

… At least 70% of small cell lung cancers express the Kit receptor tyrosine kinase and its
ligand, stem cell factor (SCF). Numerous lines of evidence have demonstrated that this …